Paper316979
Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy.
Chretien PB and 4 others. Ann N Y Acad Sci, 1979. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy. Papers, record 316979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/316979
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Thymosin | Major topic |
| Thymus Hormones | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Carcinoembryonic Antigen | |
| Carcinoma, Bronchogenic | |
| Female | |
| Fibronectins | |
| Humans | |
| Immunotherapy | |
| Leukocyte Count | |
| Lung Neoplasms | |
| Male | |
| Middle Aged | |
| Smoking | |
| T-Lymphocytes | |
| Time Factors |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19707385 | Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer. | Biologics | 2008 | https://conductscience.org/library/papers/19707385 | PubMed |
| 6609371 | Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6609371 | PubMed |
| 6239686 | Immunomodulation and therapeutic characterization of thymosin fraction five. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6239686 | PubMed |
| 6230102 | Pathogenesis of Mooren's ulcer: some new concepts. | Br J Ophthalmol | 1984 | https://conductscience.org/library/papers/6230102 | PubMed |
| 3855555 | Primary structure of rat thymus prothymosin alpha. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3855555 | PubMed |
| 1735185 | Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivo. | Clin Exp Immunol | 1992 | https://conductscience.org/library/papers/1735185 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/316979
GET https://conductscience.org/api/papers/v1/316979/authors